And the simplest, most powerful way to do that is to stay current on your vaccines. Because your immune system naturally weakens with age, vaccines are a crucial line of defense against serious ...

This is where machine learning (ML) comes in. By analyzing large, messy datasets far more efficiently than manual approaches, ML is helping researchers predict immune responses, optimize vaccine ...

Valneva (VALN) announced that the European Commission has granted marketing authorization in Europe for Valneva’s single-dose vaccine, Ixchiq, for the prevention of disease caused by the ...

The world is facing two immediate health crises concerning drugs and vaccines: affordable and reliable access to life-sparing medicines and the safety and reliability of those medicines.

meningitidis military personnel who are at increased risk of meningococcal disease close contacts of a case of IMD and for individuals at risk in an outbreak setting if the disease is caused by a ...

The Centers for Disease Control and Prevention is hiring a researcher to study the widely debunked claim that vaccines cause autism. And that person is reportedly one of the chief disseminators of ...

The Food and Drug Administration’s chief vaccine regulator has been pushed out of the agency, in what could be a troubling sign of Health Secretary Robert F. Kennedy Jr.’s efforts to advance ...

On March 10, Dr. Nisha Acharya got a letter from the National Institutes of Health terminating her grant to study the safety and effectiveness of a vaccine recommended for all adults 50 and older ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Health officials prepare to administer a vaccine ...

GENEVA — The head of leading vaccines group Gavi alliance said Thursday it has not received confirmation from the U.S. government that it might be losing more than $1 billion in pledged funding ...

Dr Sania Nishtar - head of Gavi, an alliance that buys critical vaccines for developing countries - told the BBC a cut in US funding would have a "disastrous impact on global health security".

A senior GSK scientist, who formerly worked at rival Pfizer, had told GSK colleagues that Pfizer delayed announcing the success of its Covid vaccine in 2020 until after that year’s election.